home / stock / zom / zom news

ZOM News and Press, Zomedica Pharmaceuticals Corp. From 01/17/24

Stock Information
Company Name: Zomedica Pharmaceuticals Corp.
Stock Symbol: ZOM
Market: NYSE
Website: zomedica.com
Menu
ZOM ZOM Quote ZOM Short ZOM News ZOM Articles ZOM Message Board
Get ZOM Alerts

News, Short Squeeze, Breakout and More Instantly...
ZOM - Zomedica says Q4 revenue is expected to be over $7M

2024-01-17 16:25:08 ET More on Zomedica Zomedica Corp. (ZOM) Q3 2023 Earnings Call Transcript Financial information for Zomedica For further details see: Zomedica says Q4 revenue is expected to be over $7M
ZOM - Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

ANN ARBOR, MI / ACCESSWIRE / January 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today provided a business update and will be hosting a con...

ZOM - Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Sharehol

ANN ARBOR, MI / ACCESSWIRE / January 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that it will be hosting a conference call o...

ZOM - Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth

2024-01-04 14:03:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are presenting as attractive buys right now as the valuations of larger-cap firms continue to stretch. The price-to-earnings ( P/E ) ratio of the S&P 500 , for exam...
ZOM - Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel "X-Trode" Handpiece

ANN ARBOR, MI / ACCESSWIRE / January 4, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the publication of an article validating the ...

ZOM - Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease

ANN ARBOR, MI / ACCESSWIRE / December 18, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the commercial launch of three new assays...

ZOM - Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners

ANN ARBOR, MI / ACCESSWIRE / December 6, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the presentation of new clinical data suppor...
ZOM - Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference

ANN ARBOR, MI / ACCESSWIRE / November 20, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today announced that the management team will attend the 35th Annual P...

ZOM - Zomedica Corp. (ZOM) Q3 2023 Earnings Call Transcript

2023-11-13 20:04:09 ET Zomedica Corp. (ZOM) Q3 2023 Earnings Conference Call November 13, 2023, 4:30 PM ET Company Participants Elif McDonald - Investor Relations Larry Heaton - Chief Executive Officer Peter Donato - Chief Financial Officer Conference Call ...

ZOM - Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the quarter ended Se...
Previous 10 Next 10